ArticleFrontiers in immunology2020

Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.

Antonio Barbieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.